Metraipolis › archive › dc_05d4adad73ca

The anticholinergic medication index and dementia risk: evidence from the UK Biobank and All of Us research program — Europe PMC PMID:41206104

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41206104
DOI
10.1093/ageing/afaf326
License (as archived)
solo-consultazione
Archived
2026-11-09T15:26:07.872Z
SHA-256 of the archived text
f07fa56996ca24fca77932dca43d150f5924abebeb03087b7835970e27d6129e
Stable URL of this page
https://metraipolis.com/documento/dc_05d4adad73ca

How to cite

The anticholinergic medication index and dementia risk: evidence from the UK Biobank and All of Us research program — Europe PMC PMID:41206104 — Europe PMC (en), https://europepmc.org/article/MED/41206104 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05d4adad73ca (Metraipolis archive dc_05d4adad73ca, sha256 f07fa56996ca24fca77932dca43d150f5924abebeb03087b7835970e27d6129e)
BibTeX
@misc{dc05d4adad73ca,
  title = {The anticholinergic medication index and dementia risk: evidence from the UK Biobank and All of Us research program — Europe PMC PMID:41206104},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41206104},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05d4adad73ca; sha256 f07fa56996ca24fca77932dca43d150f5924abebeb03087b7835970e27d6129e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41206104. Agents can read the archived copy with the MCP tool read_document.